TRAVERE THERAPEUTICS, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
TRAVERE THERAPEUTICS, INC. (TVTX) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $283.76 million as of 2018-03-31, per its 10-Q filed 2018-07-06.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2018-07-06
- 2018-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $283.76M.
- 2017-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $293.13M.
- 2012-11-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$64.75K.
- 2012-02-29: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -$63.08K.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2018-03-31 | $283.76M 10-Q · filed 2018-07-06 |
| 2017-12-31 | $293.13M 10-Q · filed 2018-07-06 |
| 2012-11-30 | -$64.75K 10-Q · filed 2013-03-06 |
| 2012-02-29 | -$63.08K 10-Q · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |